Symptomatic Uncomplicated Diverticular Disease (SUDD): Practical Guidance and Challenges for Clinical Management
Giacomo Calini,Mohamed A Abd El Aziz,Lucia Paolini,Solafah Abdalla,Matteo Rottoli,Giulio Mari,David W Larson
DOI: https://doi.org/10.2147/CEG.S340929
2023-03-29
Clinical and Experimental Gastroenterology
Abstract:Giacomo Calini, 1– 4 Mohamed A Abd El Aziz, 1, 5 Lucia Paolini, 6 Solafah Abdalla, 1, 7 Matteo Rottoli, 3, 4 Giulio Mari, 8 David W Larson 1 1 Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, MN, USA; 2 Department of Medical Area, University of Udine, Udine, Italy; 3 Surgery of the Alimentary Tract, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; 4 Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy; 5 Internal Medicine Department, MercyOne North Iowa, Mason City, IA, USA; 6 Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano Bicocca, Monza, Italy; 7 Department of Oncologic and Digestive Surgery, Le Kremlin-Bicêtre University Hospital, Assistance Publique des Hôpitaux de Paris, Paris, France; 8 Department of Laparoscopic and Oncological General Surgery, ASST Brianza, Desio Hospital, Desio, Italy Correspondence: Giacomo Calini, Research Collaborator, Colon and Rectal Surgery Division, Department of Surgery - Mayo Clinic, 200 First Street Southwest, Rochester, MN, 55905, USA, Email ; Symptomatic Uncomplicated Diverticular Disease (SUDD) is a syndrome within the diverticular disease spectrum, characterized by local abdominal pain with bowel movement changes but without systemic inflammation. This narrative review reports current knowledge, delivers practical guidance, and reveals challenges for the clinical management of SUDD. A broad and common consensus on the definition of SUDD is still needed. However, it is mainly considered a chronic condition that impairs quality of life (QoL) and is characterized by persistent left lower quadrant abdominal pain with bowel movement changes (eg, diarrhea) and low-grade inflammation (eg, elevated calprotectin) but without systemic inflammation. Age, genetic predisposition, obesity, physical inactivity, low-fiber diet, and smoking are considered risk factors. The pathogenesis of SUDD is not entirely clarified. It seems to result from an interaction between fecal microbiota alterations, neuro-immune enteric interactions, and muscular system dysfunction associated with a low-grade and local inflammatory state. At diagnosis, it is essential to assess baseline clinical and Quality of Life (QoL) scores to evaluate treatment efficacy and, ideally, to enroll patients in cohort studies, clinical trials, or registries. SUDD treatments aim to improve symptoms and QoL, prevent recurrence, and avoid disease progression and complications. An overall healthy lifestyle – physical activity and a high-fiber diet, with a focus on whole grains, fruits, and vegetables – is encouraged. Probiotics could effectively reduce symptoms in patients with SUDD, but their utility is missing adequate evidence. Using Rifaximin plus fiber and Mesalazine offers potential in controlling symptoms in patients with SUDD and might prevent acute diverticulitis. Surgery could be considered in patients with medical treatment failure and persistently impaired QoL. Still, studies with well-defined diagnostic criteria for SUDD that evaluate the safety, QoL, effectiveness, and cost-effectiveness of these interventions using standard scores and comparable outcomes are needed. Keywords: colonic diverticulosis, diverticulitis, irritable bowel syndrome, microbiota, treatment, probiotic Colonic diverticulosis represents the most frequent finding during colonoscopy, 1 and diverticular disease represents a common gastrointestinal condition and a worldwide burden on health-care systems. 2 Symptomatic Uncomplicated Diverticular Disease (SUDD) is a syndrome within the diverticular disease spectrum. It is characterized by localized and persistent abdominal pain with bowel movement changes and low-grade inflammation but without systemic inflammation. 3–7 SUDD is a recurrent chronic condition that negatively affects the quality of life (QoL). 8–10 As similar symptoms are present in irritable bowel syndrome (IBS), it is debated whether SUDD has to be considered a disease of its own or whether it represents the coexistence of IBS and diverticulosis. 3–7 This narrative review aims to explore the current knowledge, deliver practical guidance, and show challenges for clinical management of SUDD. This is a narrative review in which we report current knowledge, deliver practical guidance, and show challenges for the clinical management of SUDD. The SANRA scale has been used to structure the present narrative review. 11 Literature search was conducted in October 2022 on MEDLINE, searching for MeSH and keywords including diverticulosis, colonic diverticula, diverticular disease, diverticulitis, -Abstract Truncated-